Omega Diagnostics Group PLC
LSE:ODX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Omega Diagnostics Group PLC
Other Long-Term Assets
Omega Diagnostics Group PLC
Other Long-Term Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Omega Diagnostics Group PLC
LSE:ODX
|
Other Long-Term Assets
£997k
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Abingdon Health PLC
LSE:ABDX
|
Other Long-Term Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ConvaTec Group PLC
LSE:CTEC
|
Other Long-Term Assets
$63m
|
CAGR 3-Years
23%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Tristel PLC
LSE:TSTL
|
Other Long-Term Assets
£838k
|
CAGR 3-Years
-7%
|
CAGR 5-Years
0%
|
CAGR 10-Years
36%
|
|
|
Inspecs Group PLC
LSE:SPEC
|
Other Long-Term Assets
£1.7m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Advanced Medical Solutions Group PLC
LSE:AMS
|
Other Long-Term Assets
£1.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
29%
|
|
Omega Diagnostics Group PLC
Glance View
Omega Diagnostics Group Plc is a holding company, which engages in the manufacture, development, and distribution of medical diagnostics products. The company is headquartered in Alva, Stirlingshire and currently employs 171 full-time employees. The company went IPO on 2004-03-18. The principal activities of the Company and its subsidiaries are the manufacture, development and distribution of medical diagnostics products. The firm operates through two segments: Health and Nutrition and Global Health. The Health and Nutrition segment specializes in the research, development and production of kits to aid the detection of immune reactions to food. The company also provides clinical analysis to the general public, clinics and health professionals as well as supplying the consumer Food Detective test. The Global Health segment specializes in the research, development, production and marketing of kits to aid the diagnosis of infectious diseases, including COVID-19. The firm's products include FoodPrint, Food Detective, CNS lab, VISITECT CD4 Advanced Disease, VISITECT COVID-19 IgM/IgA/IgG and VISITECT COVID-19 Antigen.
See Also
What is Omega Diagnostics Group PLC's Other Long-Term Assets?
Other Long-Term Assets
997k
GBP
Based on the financial report for Mar 31, 2023, Omega Diagnostics Group PLC's Other Long-Term Assets amounts to 997k GBP.
What is Omega Diagnostics Group PLC's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
-4%
Over the last year, the Other Long-Term Assets growth was -84%. The average annual Other Long-Term Assets growth rates for Omega Diagnostics Group PLC have been -13% over the past three years , -4% over the past five years .
